Boston Scientific (BSX) PT Raised to $55 as Jefferies Sees COVID Worst in Rearview Mirror
Tweet Send to a Friend
Jefferies analyst Ken Usdin raised the price target on Boston Scientific (NYSE: BSX) to $55.00 (from $51.00) after the resurgence ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE